FloodLAMP Surveillance Information (Aug 2021 INTERNAL) The regulatory overview and FAQ memo explains how FloodLAMP frames pooled COVID-19 surveillance testing as a non-diagnostic public health activity under CMS guidance, emphasizing that no patient-specific results (e.g., “positive/negative/inconclusive”) are reported and participants are referred to CLIA-certified diagnostic testing when SARS-CoV-2 is detected in a pool. It contrasts surveillance testing, LDTs, and FDA-authorized EUA tests, cites CMS enforcement discretion and an eCFR research-lab exemption, and includes prepared language and supporting federal links to justify compliance for a municipal surveillance program. primary file regulatory surveillance FloodLAMP Surveillance Information (Aug 2021 INTERNAL).md regulatory/surveillance/FloodLAMP Surveillance Information (Aug 2021 INTERNAL).md 2021_08_01 many links to other FL archive files gdoc docx CC BY 4.0 - https://creativecommons.org/licenses/by/4.0/ 2239 3906 gfile-url xfile-github-download-url pdf-gdrive-url pdf-github-url github-markdown-url github-markdown-download-url web-pdf-url web-slides-url youtube-url web-url